GLENDIVE MEDICAL CENTER INC — History
CCN 271332 | 3-year financial timeline | COVID resilience: 58/100
🛡️ Public data only — no PHI permitted on this instance.
$53M
Latest Revenue (FY2022)
+6.5%
Revenue CAGR (3yr)
-6.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $46M | $45M | $53M | +17.7% | +6.5% |
| Operating Expenses | $49M | $49M | $56M | +13.8% | +6.6% |
| Operating Margin | -6.7% | -10.4% | -6.8% | +35.0% | +0.0% |
| Net Income | $-3M | $-5M | $-4M | +23.5% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 4,984 | 3,935 | 4,637 | +17.8% | -3.5% |
| Medicare Day % | 55% | 55% | 58% | +5.6% | +2.3% |
| Medicaid Day % | 19% | 17% | 13% | -23.0% | -17.3% |
COVID Impact & Recovery
Resilience Score: 58/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +13.5% ($46M → $53M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+6.5%
This Hospital
+7.6%
State Avg
Latest Margin
-6.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $56M | -6.8% |
| FY2024 (proj) | $59M | -6.9% |
| FY2025 (proj) | $62M | -6.9% |